Glucagon prescriptions for severe hypoglycemia rose in Medicaid beneficiaries with the introduction of newer products but likely met only a fraction of the high-risk population’s needs.

Hanmi Pharmaceutical develops obesity drugs to increase muscle while reducing fat Hanmi Pharmaceutical pioneers innovative ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

The following is a summary of “Association between incretin-based drugs and risk of cholangiocarcinoma among patients with ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...

Discover why former Real Housewives of Atlanta star Cynthia Bailey quit the weight loss drug Ozempic after giving it a try.

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

Patients with obesity and comorbid cardiovascular disease were more likely to ration prescription drugs than those without obesity.

Israeli and American researchers uncovered the role of a specific enzyme in managing blood sugar levels in a study that opens up new therapeutic possibilities for people with type 2 diabetes. Type 2 ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.